NextPlat (NXPL) Receivables - Other (2014 - 2025)
NextPlat's (NXPL) quarterly Receivables - Other came in at $1.9 million in Q4 2025, up 45.0% year-over-year from $1.3 million in Q4 2024, and up 12.47% quarter-over-quarter from $1.7 million in Q3 2025.
Analysis
NextPlat (NXPL) Receivables - Other (2014 - 2025) Analysis & Trends
NextPlat (NXPL) has reported Receivables - Other for 12 consecutive years, with $1.9 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Receivables - Other rose 45.0% year-over-year to $1.9 million in Q4 2025; TTM through Dec 2025 was $1.9 million, a 45.0% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, up 45.0% from the prior year.
- Receivables - Other was $1.9 million for Q4 2025 at NextPlat, up from $1.7 million in the prior quarter.
- Over five years, Receivables - Other peaked at $2.9 million in Q3 2023 and troughed at $77623.0 in Q1 2021.
- A 5-year average of $929933.5 and a median of $854000.0 in 2025 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other surged 2347.12% in 2023 and slumped 58.07% in 2024, its largest moves.
- Over 5 years, Receivables - Other stood at $100422.0 in 2021, then soared by 41.4% to $142000.0 in 2022, then jumped by 1200.0% to $1.8 million in 2023, then fell by 27.9% to $1.3 million in 2024, then surged by 45.0% to $1.9 million in 2025.
- The last three Receivables - Other figures came in at $1.9 million (Q4 2025), $1.7 million (Q3 2025), and $854000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 854,000.00 |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Sep 30, 2023 | 2.95 Mn |
| Jun 30, 2023 | 175,410.00 |
| Dec 31, 2022 | 142,000.00 |
| Sep 30, 2022 | 120,359.00 |
| Jun 30, 2022 | 120,816.00 |
| Mar 31, 2022 | 92,144.00 |
| Dec 31, 2021 | 100,422.00 |
| Sep 30, 2021 | 97,909.00 |
| Jun 30, 2021 | 85,727.00 |
| Mar 31, 2021 | 77,623.00 |
| Dec 31, 2020 | 75,556.00 |